KMTS

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Held by: VTI IWM VXF IWO SCHA VTWO FMED IWN ONEQ GINN

Index	RUT	P/E	-	EPS (ttm)	-2.47	Insider Own	66.28%	Shs Outstand	51.35M	Perf Week	12.84%
Market Cap	956.62M	Forward P/E	-	EPS next Y	-1.98	Insider Trans	0.05%	Shs Float	17.32M	Perf Month	23.95%
Enterprise Value	763.34M	PEG	-	EPS next Q	-0.61	Inst Own	32.18%	Short Float	12.92%	Perf Quarter	-4.41%
Income	-125.19M	P/S	15.99	EPS this Y	53.46%	Inst Trans	15.00%	Short Ratio	6.26	Perf Half Y	-11.96%
Sales	59.81M	P/B	4.66	EPS next Y	17.07%	ROA	-65.19%	Short Interest	2.24M	Perf YTD	-14.70%
Book/sh	4.00	P/C	4.03	EPS next 5Y	37.13%	ROE	-130.38%	52W High	26.15 -28.76%	Perf Year	-
Cash/sh	4.63	P/FCF	-	EPS past 3/5Y	-18.44% -	ROIC	-50.17%	52W Low	13.25 40.60%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	179.99% -	Gross Margin	46.70%	Volatility	5.24% 6.08%	Perf 5Y	-
Dividend TTM	-	EV/Sales	12.76	EPS Y/Y TTM	-21.37%	Oper. Margin	-177.85%	ATR (14)	1.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.55	Sales Y/Y TTM	115.05%	Profit Margin	-209.30%	RSI (14)	61.43	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	6.72	EPS Q/Q	-116.18%	SMA20	8.55%	Beta	-	Target Price	26.83
Payout	-	Debt/Eq	0.22	Sales Q/Q	71.40%	SMA50	14.19%	Rel Volume	0.50	Prev Close	18.19
Employees	330	LT Debt/Eq	0.21	Earnings	Sep 11 AMC	SMA200	-6.09%	Avg Volume	357.73K	Price	18.63
IPO	Mar 06, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	-320.95% 9.99%	Trades		Volume	48,107	Change	2.42%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-31-25	Initiated	Wolfe Research	Outperform	$29
Mar-31-25	Initiated	Wells Fargo	Overweight	$28
Mar-31-25	Initiated	Stifel	Buy	$28
Mar-31-25	Initiated	Piper Sandler	Overweight	$27
Mar-31-25	Initiated	Goldman	Neutral	$24
Mar-31-25	Initiated	BofA Securities	Buy	$30

Today 04:55AM	Adobe earnings on tap as stock badly lags the broader market (MarketWatch)
04:13AM	Stock Market Today: S&P 500 and Nasdaq hold record highs, Dow near peak, as AI excitement lingers and investors hope CPI inflation data will confirm Fed rate cut trajectory. (MarketWatch)
Aug-28-25 08:00AM	Kestra Medical Technologies, Ltd. to Report First Quarter Fiscal 2026 Financial Results (GlobeNewswire)
Aug-04-25 08:05AM	RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors (GlobeNewswire)
Jul-31-25 08:31AM	InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors (GlobeNewswire)
03:20PM	Loading…
Jul-29-25 03:20PM	Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival (Bloomberg)
Jul-17-25 08:00AM	Kestra Medical Technologies Wins 2025 Top Workplaces Industry Award, A National Recognition (GlobeNewswire) +7.23%
Jul-16-25 09:28PM	Kestra Stock Slips as Heavy Q4 Loss Overshadows Big Revenue Gains (GuruFocus.com) -5.77%
03:05AM	Kestra Medical Technologies Ltd (KMTS) Q4 2025 Earnings Call Highlights: Record Revenue Growth ... (GuruFocus.com)
Jul-15-25 04:01PM	Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results (GlobeNewswire) +5.57%
Jul-01-25 08:00AM	Kestra Medical Technologies, Ltd. to Report Fourth Quarter and Fiscal Year 2025 Results on July 15 (GlobeNewswire)
Jun-23-25 08:00AM	Kestra Medical Technologies Announces Inclusion in the Russell 2000 and Russell 3000 Indexes (GlobeNewswire) +6.45%
Jun-05-25 08:00AM	Kestra Medical Technologies Announces Appointment of Conor Hanley to its Board of Directors (GlobeNewswire)
May-13-25 08:00AM	Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year 2025 Mountain West Award Finalist (GlobeNewswire)
Apr-30-25 08:00AM	Kestra Medical Technologies to Participate in Upcoming Investor Conferences (GlobeNewswire)
08:00AM	Loading…
Apr-29-25 08:00AM	Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025 (GlobeNewswire)
Apr-23-25 08:00AM	Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025 (GlobeNewswire)
Apr-14-25 04:01PM	Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results (GlobeNewswire)
Apr-02-25 04:05PM	Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14 (GlobeNewswire) -6.54%
Mar-14-25 04:05PM	Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering (GlobeNewswire) +16.50%
Mar-07-25 05:30PM	Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering (GlobeNewswire)
Mar-05-25 11:03PM	Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)
Feb-26-25 08:00AM	Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering (GlobeNewswire)

Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company was founded by Brian Webster and Phillip D. Foshee in 2014 and is headquartered in Kirkland, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COHEN RAYMOND W	Director	Mar 07 '25	Buy	17.00	17,000	289,000	29,994	Sep 08 05:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Kestra Medical Technologies Ltd

Upgrade your FINVIZ experience